Ranbaxy Suffers Rs 524-crore Net Loss in June Quarter
Ranbaxy Labs on Wednesday posted a consolidated net loss of Rs 524.24 crore for the quarter ended June 30, 2013, […]
CENTRUM-BROKING
USFDA Withdrwas Sales Ban as Indian Pharma Companies Take Corrective Measures
A new recommendation has come in for the Indian drug companies. Most Indian drug companies that were penalised for violating […]
